COMMUNIQUÉS West-GlobeNewswire

Cynet Releases v4.33 Unveiling a New Cross-Site Dashboard and Enhanced SIEM Capabilities
15/07/2026
New enhancements deliver major advancements for IT and security teams to maximize scale, speed and interoperability of security environments BOSTON, July 15, 2026 (GLOBE NEWSWIRE) -- Cynet , the only unified, AI-powered [...]
SBC Medical to Participate in the “Health, Wellness & Longevity” Virtual Conference Presented by Maxim Group LLC on Wednesday, July 22nd at 10:30 a.m. ET
15/07/2026
IRVINE, Calif., July 15, 2026 (GLOBE NEWSWIRE) -- SBC Medical Group Holdings Incorporated (Nasdaq: SBC) (“SBC Medical” or the “Company”), a Medical Services Organization providing management support across a wide range [...]
Inteleos Names First Chief Product Officer to Lead New Healthcare Innovation Division
15/07/2026
Reggie Jones joins the global nonprofit to build solutions that expand access to quality care ROCKVILLE, Md., July 15, 2026 (GLOBE NEWSWIRE) -- Inteleos has named Reggie Jones as its first Chief Product Officer, [...]
Rectify Pharmaceuticals Announces Appointment of Constantine Chinoporos as Executive Chairman
15/07/2026
The appointment comes as Rectify transitions into a clinical-stage company following the recent initiation of the Phase 1 study of RTY-406, its lead program for hepatobiliary diseases. Rectify is developing oral [...]
NewcelX Granted Patent in Brazil for NCEL-101 in Type 1 Diabetes, Expanding Global IP Portfolio
15/07/2026
Brazil patent complements U.S. patent portfolio for NCEL-101, strengthening global position in the type 1 diabetes market ZURICH, July 15, 2026 (GLOBE NEWSWIRE) -- NewcelX Ltd. (“NewcelX”; Nasdaq: NCEL), a clinical- [...]
Lark Health Partners with Samsung to Bring AI-Powered Health Coach to U.S. Seniors
15/07/2026
Through the integration Samsung users will have access to health coaching and eligible Medicare beneficiaries access to Lark’s proven chronic disease management programs, at no out-of-pocket cost MOUNTAIN VIEW, Calif., [...]
Alembic Therapeutics LLC Announces Exclusive U.S. Distribution of NUVESSA® (metronidazole vaginal gel 1.3%)
15/07/2026
BEDMINSTER, N.J., July 15, 2026 (GLOBE NEWSWIRE) -- Alembic Therapeutics LLC today announced that it has become the exclusive U.S. distributor of NUVESSA® (metronidazole vaginal gel 1.3%), an FDA-approved prescription [...]
Nadia Care Named ACAP Preferred Vendor, Scaling Community-Centered, Culturally-Informed Care to Combat the Maternal Health Crisis
15/07/2026
WASHINGTON, July 15, 2026 (GLOBE NEWSWIRE) -- Today, maternal health company Nadia Care announced its selection as a Preferred Vendor by the Association for Community Affiliated Plans (ACAP). The designation provides [...]
New FDA-Cleared Single-Step Immunoblot IGeneX Tests Improve Early Detection of Lyme Disease, Study Finds
15/07/2026
Study published in Microbiology Spectrum shows single-step tests outperform conventional two-tier testing in early-stage Lyme disease MILPITAS, Calif., July 15, 2026 (GLOBE NEWSWIRE) -- IGeneX, Inc ., a specialty [...]
Profound Medical: Autonomous Robotics and Incisionless Surgery to Have Exceptional Presence at SRS2026
15/07/2026
TORONTO, July 15, 2026 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”) is pleased to announce that its MRI-guided, AI-powered, Robotically-Driven and Incisionless TULSA [...]
Attovia Therapeutics Appoints John W. Smither to Board of Directors
15/07/2026
Mr. Smither brings extensive public company board and audit committee experience in the biotechnology sector SAN CARLOS, Calif., July 15, 2026 (GLOBE NEWSWIRE) -- Attovia Therapeutics, Inc. (“Attovia” or the “Company [...]
iTonic Holdings Ltd Issues an Update on its Effort to Develop AI-Powered Cloud Healthcare Platform Designed to Support Nuclear Medicine Treatment Planning and with Potential Future Expansion into Digital Care Delivery
15/07/2026
New cloud-based platform is being developed to integrate artificial intelligence, automated quality control and healthcare data connectivity to support next-generation precision medicine workflows. Beijing, China, July [...]
Ernexa Therapeutics Receives Independent Validation of ERNA-101 with Complete Tumor Clearance and Durable Survival in Ovarian Cancer Models Ahead of Planned Clinical Entry
15/07/2026
Independent CRO Successfully Reproduces ERNA-101 Combination Data in Larger Preclinical Study, Significantly Strengthening Confidence as Company Advances Toward IND ERNA-101 Plus Anti-PD-1 Achieved Complete Tumor [...]
BriaCell Arranges Scalable Manufacturing with FUJIFILM Biotechnologies for Bria-IMT™
15/07/2026
Arrangement with FUJIFILM Biotechnologies California provides manufacturing capacity for the remainder of BriaCell’s pivotal Phase 3 study and commercial scalability potential Bria-IMT is currently being evaluated in [...]
Cellectar Biosciences Announces Publication of Phase 1 Study of Iopofosine I 131 in Peer-Reviewed Journal Cancers
15/07/2026
Demonstrated Favorable Safety Profile and Preliminary Clinical Activity in Relapsed/Refractory Multiple Myeloma Publication Supports Continued Development of Iopofosine I 131 as a Novel Targeted Radiotherapeutic Across [...]
Repligen to Report Second Quarter 2026 Financial Results
15/07/2026
Webcast and Conference Call to Be Held Tuesday, July 28, 2026, at 8:00 a.m. ET WALTHAM, Mass., July 15, 2026 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), today announced that the Company will report its [...]
Milestone Scientific Launches First Phase of AI Strategy with Pilot Debut of Milo, an AI-enabled Digital Engagement Platform, at ASPN 2026
15/07/2026
AI-powered Initiative Aims to Enhance Customer Engagement, Accelerate Commercial Execution and Support Long-Term Growth Visit booth #112 in the Sparkle Ballroom at Fontainebleau Miami Beach for a live demonstration of [...]
BioAdaptives® Inc. Announces XcellaraHeart™, a Cardiovascular Wellness Formula Built on Xcellara’s Human-Clinical Data Demonstrating a 268.8% Increase in Circulating Stem/Progenitor-Type Cells
15/07/2026
The formula combines the Xcellara™ mobilization base with Tanshinone IIA, a Danshen-derived compound studied for its effects on the SDF-1α/CXCR4 signaling pathways involved in cellular trafficking and cardiovascular [...]
Acumen Pharmaceuticals Highlights Enhanced Brain Delivery™ (EBD™) Program Data and Early Alzheimer’s Disease Insights at the Alzheimer’s Association International Conference (AAIC®) 2026
15/07/2026
EBD™ bispecific antibodies targeting both AβOs and hTfR showed improved brain penetration compared to the native anti-AβO antibodies, which may enable administration with a low-volume delivery device and reduce the [...]

Pages